Skip to main content
Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial.
Published Web Location
http://europepmc.org/articles/PMC4324195?pdf=renderNo data is associated with this publication.
Abstract
GeneXpert® MTB/RIF (Xpert) is now widely distributed in high human immunodeficiency virus (HIV)/tuberculosis (TB)-burden countries. Yet, whether the test improves patient-important outcomes within HIV treatment programs in limited resource settings is unkn
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.